TARIS Biomedical Receives $12,500,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=224e24f0-4566-4fbc-8c62-50e214fe3e69&Preview=1 - Date
4/2/2013 - Company Name
TARIS Biomedical - Mailing Address
99 Hayden Avenue Lexington, MA 02421 - Company Description
TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products. - Website
http://www.tarisbiomedical.com - Transaction Type
Venture Equity - Transaction Amount
$12,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
The company will use the financing to continue clinical advancement of its lead product candidate, LiRIS. - M&A Terms
- Venture Investor
Flagship Ventures - Venture Investor
Flybridge Capital Partners - Venture Investor
Polaris Partners - Venture Investor
Third Rock Ventures
